A299170 Stock Overview
Engages in the distribution of medicines and medical devices.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 1/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
WSI Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩1,406.00 |
52 Week High | ₩2,645.00 |
52 Week Low | ₩1,400.00 |
Beta | -0.25 |
11 Month Change | -8.10% |
3 Month Change | -18.45% |
1 Year Change | -26.92% |
33 Year Change | -46.13% |
5 Year Change | n/a |
Change since IPO | -59.01% |
Recent News & Updates
Shareholder Returns
A299170 | KR Healthcare | KR Market | |
---|---|---|---|
7D | -5.4% | 1.0% | 0.8% |
1Y | -26.9% | 1.8% | 3.9% |
Return vs Industry: A299170 underperformed the KR Healthcare industry which returned 1.8% over the past year.
Return vs Market: A299170 underperformed the KR Market which returned 3.9% over the past year.
Price Volatility
A299170 volatility | |
---|---|
A299170 Average Weekly Movement | 3.9% |
Healthcare Industry Average Movement | 7.4% |
Market Average Movement | 5.4% |
10% most volatile stocks in KR Market | 11.4% |
10% least volatile stocks in KR Market | 2.6% |
Stable Share Price: A299170 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A299170's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2016 | 28 | Jeang-Sub Park | wsi-healthcare.com |
WSI Co., Ltd. engages in the distribution of medicines and medical devices. The company was founded in 2016 and is headquartered in Seoul, South Korea.
WSI Co., Ltd. Fundamentals Summary
A299170 fundamental statistics | |
---|---|
Market cap | ₩42.22b |
Earnings (TTM) | ₩1.61b |
Revenue (TTM) | ₩31.92b |
26.3x
P/E Ratio1.3x
P/S RatioIs A299170 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A299170 income statement (TTM) | |
---|---|
Revenue | ₩31.92b |
Cost of Revenue | ₩21.20b |
Gross Profit | ₩10.72b |
Other Expenses | ₩9.12b |
Earnings | ₩1.61b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 53.48 |
Gross Margin | 33.59% |
Net Profit Margin | 5.03% |
Debt/Equity Ratio | 49.0% |
How did A299170 perform over the long term?
See historical performance and comparison